Neo Ivy Capital Management’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
VCM
VPM
Neo Ivy Capital Management's PFE Position: Q1 2026 in Review
Neo Ivy Capital Management sold out of Pfizer (PFE) in Q1 2026, closing a stake of 140,529 shares — an estimated $3.5M sold.
Neo Ivy Capital Management first reported a position in PFE in Q1 2019 and held it in 16 quarters. The position peaked at $3.73M in Q4 2024. 2,939 funds tracked by Wall St. Rank hold PFE as of Q1 2026.
- Neo Ivy Capital Management reported no remaining Pfizer position as of Q1 2026 after selling out during the quarter.
- Neo Ivy Capital Management sold 140,529 Pfizer shares in Q1 2026, an estimated $3.5M.
- Neo Ivy Capital Management first reported a position in Pfizer in Q1 2019 and held it in 16 quarters.
- Neo Ivy Capital Management's Pfizer position peaked at $3.73M in Q4 2024.
- 2,939 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.
Based on Neo Ivy Capital Management's 13F filing for Q1 2026, filed 15 May 2026.